Krsnaa Diagnostics Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Krsnaa Diagnostics Ltd is ₹ 497.75 as of 23 Oct 15:30 . The P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The revenue of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The ebitda of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The net profit of Vanta Bioscience Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Krsnaa Diagnostics Ltd or Vanta Bioscience Ltd?

Market cap of Krsnaa Diagnostics Ltd is 1,614 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd?

The stock performance of Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd?

As of October 24, 2026, the Krsnaa Diagnostics Ltd stock price is INR ₹497.75. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Krsnaa Diagnostics Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.